Description
Hydroxytyrosol (HT) is a naturally occurring compound being studied in clinical trials for colorectal cancer. It is currently being investigated in combination with standard chemotherapy regimens (like FOLFIRI or FOLFOX, often with biologics like Cetuximab or Bevacizumab) for patients with advanced or metastatic colorectal cancer. The goal of these early-phase trials is to determine the safety and potential effectiveness of adding hydroxytyrosol to existing treatments. It is taken orally, as a capsule, daily. These trials are in the early phase (Phase 1), meaning they primarily focus on safety and finding the right dose.
Mechanism of Action
Hydroxytyrosol is a polyphenol found in olive oil and other plants. In the context of this trial, it is being given alongside standard chemotherapy for colorectal cancer. The specific way hydroxytyrosol might work against cancer cells, or how it interacts with chemotherapy, is still being investigated. Researchers are looking at its potential effects on tumor growth and response to chemotherapy.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.